Abstract III: Adaptive Immunity and Transplant Outcomes

Speaker(s)

• 

  Amit Kalra, MBBS, MSc

  University of Calgary
• 

  Alberto Lima, PhD (he/him/his)

  Clinical Histocompatibility Consultant
  IGEN/AFIP and Federal University of Parana
  Curitiba, Parana, Brazil
• 

  Kristina Olack, MS, MLS

  Atrium Health
• 

  Rebecca Sosa, PhD, F(ACHI)

  UCLA Immunogenetics Center
• 

  Nicole Valenzuela, PhD, F(ACHI)

  UCLA
• 

  Xiaohai (Sam) Zhang, PhD

  Cedars Sinai Medical Center

Moderator(s)

• 

  Matthew Najor, PhD, F(ACHI)

  University of Michigan Medicine
• 

  David Pinelli, PhD, F(ACHI) (he/him/his)

  Research Assistant Professor
  Northwestern University
  Chicago, Illinois

Presentations:

• 4:45 PM - 5:00 PM US PDT

  Non-Permissive Hla-Dpb1 Mismatches are Associated with Increased 1-Year Mortality after Unrelated Donor Hematopoietic Cell Transplantation for Non-Malignant Disorders
  

  Speaker: Joselito Getz, MSc – Complexo Hospital de Clínicas - Federal University of Paraná
• 5:00 PM - 5:15 PM US PDT

  Reconstitution of T Cells at Three Months after Stem Cell Transplant Influences the Discovery of Predictive Markers of Relapse
  

  Speaker: Amit Kalra, MBBS, MSc – University of Calgary
• 5:15 PM - 5:30 PM US PDT

  Serological reactivity of HLA alleles is dependent on race/ethnicity
  

  Speaker: Nicole Valenzuela, PhD, F(ACHI) – UCLA
• 5:30 PM - 5:45 PM US PDT

  Treatment with Bi-Specific Antibody Blinatumomab Effectively Reduces HLA Antibodies
  

  Speaker: Xiaohai (Sam) Zhang, PhD – Cedars Sinai Medical Center
• 5:45 PM - 6:00 PM US PDT

  Ischemia-Reperfusion Injury Drives Increased Allosensitization to HLA-B, DQB1 and DPB1 and Leads to Poor Outcomes in Liver Transplant Recipients
  

  Speaker: Rebecca Sosa, PhD, F(ACHI) – UCLA Immunogenetics Center
• 6:00 PM - 6:15 PM US PDT

  North Carolina Flow-XM Collaboration
  

  Speaker: Kristina Olack, MS, MLS – Atrium Health